WIN-2299
WIN-2299 is an anticholinergic drug.[1] Human reactions to WIN-2299 include sedation (2 mg), LSD-like reactions (6 mg), and an acute delirious episode (10 mg).[2]
Names | |
---|---|
IUPAC name
2-Diethylaminoethyl cyclopentylhydroxy-(2-thienyl)-acetate | |
Identifiers | |
| |
3D model (JSmol) |
|
ChemSpider | |
ECHA InfoCard | 100.035.835 |
EC Number |
|
PubChem CID |
|
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C17H27NO3S | |
Molar mass | 325.47 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
References
- Luduena, FP; Lands, AM (1954). "An investigation of the pharmacological actions of three potent antispasmodic compounds and their corresponding metho-salts". The Journal of Pharmacology and Experimental Therapeutics. 110 (3): 282–92. PMID 13143475.
- Pennes, HH; Hoch, PH (1957). "Psychotomimetics, clinical and theoretical considerations: Harmine, Win-2299 and nalline". The American Journal of Psychiatry. 113 (10): 887–92. doi:10.1176/ajp.113.10.887. PMID 13402982.
mAChRs |
| ||||
---|---|---|---|---|---|
Precursors (and prodrugs) | |||||
See also: Receptor/signaling modulators • Nicotinic acetylcholine receptor modulators • Acetylcholine metabolism/transport modulators |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.